# Edesa Biotech, Inc.: Form SCHEDULE 13D, filed Feb 18, 2025

- Company: [Edesa Biotech, Inc.](/companies/edsa.md) (CIK 1540159)
- Form: SCHEDULE 13D
- Filed: 2025-02-18
- Accepted by EDGAR: Feb 18, 2025, 17:48 ET
- Period: not reported
- Accession: 0000921895-25-000528
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1540159/000092189525000528/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1540159/000092189525000528/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1540159/000092189525000528/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 18, 2025.
Source: SEC EDGAR, the filing index for accession 0000921895-25-000528. Last ingested by Listed: Nov 5, 2026, 19:56 ET. No prices; not investment advice.